Upgrade to SI Premium - Free Trial

BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)

May 12, 2026 10:34 AM
BMO Capital analyst Evan David Seigerman reiterated a Market Perform rating and $60.00 price target on Bristol-Myers Squibb Co. (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments